Clinical Trial Update: ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial [Phase 2]

View source ↗

Summary

Phase 2 trial assessing anti-IL-6 treatment in myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease
• Myocardial Infarction

Drugs mentioned

• Anti-IL-6 treatment

Snippet

Sponsor: Oslo University Hospital | Conditions: Coronary Disease, Myocardial Infarction | Phase 2 | Status: COMPLETED